With the public availability of ChatGPT 3.5 in fall 2022 at the latest, artificial intelligence in the sense of large language models (LLMs) is on everyone’s lips. However, it is often forgotten that this is only the provisional end point of decades of development of artificial intelligence, which, despite its great potential, still has many limitations. The question for practising doctors is how this technology can be used sensibly in everyday clinical practice – and how it should not be used.
Autoren
- Dr. med. Lukas Dürst
- Dr. med. Marc Oertle
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
Related Topics
You May Also Like
- Pneumococcal conjugate vaccine (PCV)
Best possible serotype coverage in the respective age group
- Psoriasis: intervening in the inflammatory cascade
Advantages of early biologic therapy and oral peptide as a beacon of hope
- AI-supported imaging and new biomarkers
CHD diagnostics update
- Bipolar disorder, anxiety disorder, depression
Lurasidone as monotherapy for bipolar I depression with anxiety symptoms
- Arterial hypertension: ESC guideline 2024 in focus
New category “elevated blood pressure” – what are the therapeutic implications?
- Palliative care symptom and needs assessment.
What screening tools are helpful?
- Low-grade pediatric gliomas
Consideration of the tumor microenvironment opens up new treatment options
- Patient-centered rounds in medicine